SynthesisBMJ open2025

Dual checkpoint inhibitor therapy versus dual targeted therapy of untreated metastatic BRAF-mutant melanoma: a systematic review of randomised controlled trials.

Frank Peinemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.